Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Mirion Technologies Inc. Class A

In a report released today, Andrew Kaplowitz from Citi maintained a Buy rating on Mirion Technologies, with a price target of $33.00. Kaplowitz cov...

Citi Sticks to Its Buy Rating for Mirion Technologies (MIR)

The latest update is out from Mirion Technologies ( ($MIR) ). On December 8, 2025, Mirion Technologies, through its subsidiaries, entered into Amen...

Mirion Technologies Enters New $450M Credit Agreement

The latest update is out from Mirrabooka Investments Ltd ( ($AU:MIR) ). Mirrabooka Investments Limited announced its estimated pre-tax net tangible...

Mirrabooka Investments Reports Estimated NTA Backing

An announcement from MIRA Pharmaceuticals, Inc. ( ($MIRA) ) is now available. On December 5, 2025, MIRA Pharmaceuticals, Inc. announced an increase...

MIRA Pharmaceuticals Expands Stock Offering by $15M

Mirrabooka Investments Ltd ( ($AU:MIR) ) has shared an announcement. Mirrabooka Investments Limited has announced key dates for the first half of 2...

Mirrabooka Investments Announces Key 2026 Dates

Mirion Technologies ( ($MIR) ) just unveiled an update. On December 1, 2025, Mirion Technologies, Inc. completed its acquisition of WCI-Gigawatt In...

Mirion Technologies Completes Acquisition of WCI-Gigawatt

Mirrabooka Investments Ltd ( ($AU:MIR) ) has shared an announcement. Mirrabooka Investments Limited has announced its estimated net tangible asset ...

The latest announcement is out from Medmira ( ($TSE:MIR) ). MedMira Inc. reported its FY2025 financial results, highlighting significant product la...

MedMira Inc. Reports FY2025 Financial Results and Strategic Developments

Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings from Top Wall Street ...

3 Best Stocks to Buy Now, 11/25/2025, According to Top Analysts

Mirrabooka Investments Ltd ( ($AU:MIR) ) has shared an update. Mirrabooka Investments Limited announced an estimated pre-tax net tangible asset (NT...

The latest update is out from Mirrabooka Investments Ltd ( ($AU:MIR) ). Mirrabooka Investments Limited announced an estimated pre-tax net tangible ...

Market Cap	$6.98B	P/E Ratio	56.07
52W High	$30.28	52W Low	$12.00
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-21.6%	52W Position	69.3%
Overall Score	61	Value Score	50
Quality Score	71	Technical Score	63

EPS Current Est	$0.44	EPS Next Est	$0.57
EPS Growth Est	+29.5%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MIR	$24.67	-6.16%	2.73M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MIR	$24.67	-6.2%	2.73M
3
4
5
6

MIR

MIR

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Mirion Technologies Inc. Class A Data in Excel

Get Mirion Technologies Inc. Class A Data in Excel